Full-Time

Manager – Manufacturing Engineering

Posted on 6/11/2025

Agilent Technologies

Agilent Technologies

10,001+ employees

eProcurement solutions for streamlined purchasing

Compensation Overview

$124.2k - $194k/yr

+ Bonus + Stock

Senior

Company Does Not Provide H1B Sponsorship

Fort Lupton, CO, USA + 1 more

More locations: Boulder, CO, USA

Category
Manufacturing Engineering
Mechanical Engineering
Requirements
  • Bachelor's degree in chemistry, biology, engineering or related life science field; or an equivalent combination of education and related experience.
  • 5+ years of experience in manufacturing engineering or process engineering, preferably in a regulated industry (e.g., pharmaceuticals, biotech, medical devices).
  • 1+ years of leadership or supervisory experience managing engineering teams or cross-functional projects is helpful.
  • Prior experience in a GMP manufacturing facility preferred.
Responsibilities
  • Oversees and supports the transfer and scale-up of new processes from Process Development into Manufacturing.
  • Attends and participates in project team meetings to develop and execute project plans.
  • Interfaces with Process Development, Project Management, and Manufacturing to ensure small-scale development activities will scale to manufacturing equipment and systems.
  • Responsible for the review and approval of technology transfer documents from Process Development.
  • Responsible for writing or reviewing new process documentation (master batch records or data capture forms) and automated equipment methods.
  • Coordinate the revision of standard operating procedures (SOPs) as required to support the transfer.
  • Supervises activities and projects of the MFG Engineers. Provides technical guidance on project execution and implementation.
  • Directs MFG Engineers during the scale-up existing processes in Manufacturing. Oversees, supports, and is responsible for writing and/or reviewing scale-up batch documentation, change controls and automated equipment methods. Coordinate the creation and/or revision of SOPs as required to support the scale-up.
  • Responsible for the generation and/or review of batch summaries for all batches produced in the manufacturing facilities.
  • Oversees, supports, and is responsible for communicating future development requirements or opportunities to the project team.
  • Assist manufacturing with problem solving and trouble-shooting process or process equipment including interfacing directly with external vendors and customers to clearly and concisely discuss and resolve the issue to meet production timelines, quality policies, and customer expectations.
  • Actively lead or participate in the investigation of major process deviations including providing technical assistance to Quality Assurance (QA) on the final product impact assessment and identification of root cause as necessary.
Desired Qualifications
  • Prior experience in a GMP manufacturing facility preferred.

Agilent Technologies provides electronic procurement services that help businesses streamline their purchasing processes. Their suite of eProcurement services allows clients to integrate their pricing into existing platforms, access a hosted catalog, and conduct transactions without paper. This system is designed to help businesses quickly find and buy the products they need at the right price, enhancing productivity through automation and simplified workflows. Agilent stands out from competitors by focusing on reliability and quality, serving a wide range of clients who benefit from their expertise. The company's goal is to lower costs and increase profitability for its clients by making the procurement process more efficient.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisitions like Sigsense enhance Agilent's AI capabilities in lab operations.
  • The trend towards paperless transactions boosts Agilent's service efficiency and appeal.
  • Automation in procurement is expected to increase, benefiting Agilent's offerings.

What critics are saying

  • Integration challenges from acquiring BIOVECTRA may disrupt Agilent's operations.
  • Multiple acquisitions could stretch Agilent's resources and management focus.
  • Increased competition from funded companies like RareCyte and Elegen may challenge Agilent.

What makes Agilent Technologies unique

  • Agilent offers a comprehensive suite of eProcurement services for streamlined purchasing.
  • The company focuses on automation and paperless transactions to enhance business productivity.
  • Agilent's hosted catalog and pricing integration simplify procurement processes for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Performance Bonus

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

6%

2 year growth

5%
Business Wire
Jul 30th, 2024
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology

Agilent has acquired Sigsense Technologies, a startup that uses artificial intelligence and power monitoring to optimize lab operations.

Biovectra
Jul 22nd, 2024
Agilent Technologies to Acquire BIOVECTRA Inc., Creating New Synergistic Opportunities to Improve Patient Care | BIOVECTRA

CHARLOTTETOWN, Prince Edward Island and SANTA CLARA, California – July 22, 2024 BIOVECTRA Inc. and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an agreement for Agilent to acquire BIOVECTRA, a Canadian-based Contract Development and Manufacturing Organization, from H.I.G. Capital for $925 million. The acquisition provides the ability to expand the range of [...]Read More...

Finsmes
Jun 27th, 2024
RareCyte Secures $20M Financing

RareCyte, a Seattle, WA-based Life Sciences company providing precision biology platforms including instruments, reagents, software, and services, raised $20M in funding

Business Wire
May 14th, 2024
Elegen Raises $35 Million In Series B To Accelerate Expansion Into Clinical Manufacturing

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA synthesis and production, today announced a Series B financing of $35 million led by Triatomic Capital. Also joining the round are strategic investors GSK, which recently entered a collaboration and licensing agreement with Elegen to use their proprietary cell-free DNA manufacturing technology in developing GSK’s vaccines and medicines, and John Ballantyne, co-founder of Aldevron. Elegen’s current investors, including Andreessen Horowitz (a16z Bio + Health), KdT Ventures, 8VC, Digitalis Ventures, ACVC Partners, Alix Ventures, AME Cloud Ventures and Agilent Technologies, also participated. The new funds will accelerate the extension of the company’s rapidly growing ENFINIA™ DNA product line across clinical workflows providing turnkey production of GMP-compliant DNA for clinical development of genetic medicines. “The age of genetic medicines is here, but these powerful modalities require innovative new manufacturing approaches to supply the critical input DNA material for rapid discovery, development and then wide-scale production,” said Matthew Hill, Ph.D., Elegen Founder and CEO. “With this investment, we will continue to push the boundaries of DNA synthesis to accelerate upstream discovery and enable rapid and streamlined deployment of new clinical modalities.”

GenomeWeb
Apr 3rd, 2024
Biofidelity Raises $24M to Expand US Commercialization of Lung Cancer Test, Product Pipeline

The firm said it also plans to use the money, which brings its total raised to $60 million, to establish a dedicated manufacturing facility in the UK.